AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27646624 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation (task-specific motor training)
Number of subjects: 9
Study 24811564 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood donors who completed the screening questionnaire
Number of subjects: 854
Study 24811564 — intervention group
Group type: COMPARATOR
Intervention: Blood donors who did not complete the screening questionnaire
Number of subjects: 854
Study 24106570 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (intramedullary nailing)
Number of subjects: 148
Study 24106570 — intervention group
Group type: COMPARATOR
Intervention: Skeletal traction
Number of subjects: 148
Study 20712245 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological gender—masculinity dimension
Number of subjects: 37
Study 20712245 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety (as a state and as a feature)
Number of subjects: 37
Study 20712245 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping with stress
Number of subjects: 37
Study 17437819 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant weekly docetaxel (35 mg/m² weekly for 6 cycles, starting 4 to 12 weeks post-surgery)
Number of subjects: 77
Study 17437819 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant weekly docetaxel
Number of subjects: 77
Study 15554993 — intervention group
Group type: EXPERIMENTAL
Intervention: 170 degrees wide-angle colonoscope
Number of subjects: 50
Study 15554993 — intervention group
Group type: COMPARATOR
Intervention: Standard 140 degrees angle of view colonoscope
Number of subjects: 50
Study 11728297 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure- and volume-limited ventilation according to the ARDS Network protocol
Number of subjects: 0
Study 11728297 — intervention group
Group type: EXPERIMENTAL
Intervention: Open lung approach to mechanical ventilation
Number of subjects: 0
Study 11728297 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide therapy
Number of subjects: 0
Study 11728297 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 0
Study 11728297 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids in the late phase of ARDS
Number of subjects: 0
Study 11728297 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term follow-up of ARDS survivors
Number of subjects: 0
Study 9563867 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 40 microg/kg + Glycopyrronium 8 microg/kg (Ne-Glyc)
Number of subjects: 84
Study 9563867 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 40 microg/kg + Atropine 20 microg/kg (Ne-Atr)
Number of subjects: 84
Study 9563867 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium 200 microg/kg + Atropine 300 microg (Edr-Atr (1))
Number of subjects: 84
Study 9563867 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium 500 microg/kg + Atropine 7 microg/kg (Edr-Atr (2))
Number of subjects: 84
Study 8555574 — intervention group
Group type: EXPERIMENTAL
Intervention: Centri-Safe valve (experimental group)
Number of subjects: 24
Study 8555574 — intervention group
Group type: COMPARATOR
Intervention: Control (no valve)
Number of subjects: 24
Study 3323130 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone (23 patients)
Number of subjects: 45
Study 3323130 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (22 patients)
Number of subjects: 45
Study 31562412 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinpro 5000
Number of subjects: 120
Study 31562412 — intervention group
Group type: COMPARATOR
Intervention: Clinpro Tooth Crème
Number of subjects: 120
Study 31562412 — intervention group
Group type: COMPARATOR
Intervention: MI Paste Plus
Number of subjects: 120
Study 30403369 — intervention group
Group type: EXPERIMENTAL
Intervention: UCL reconstruction with docking technique
Number of subjects: 18
Study 30403369 — intervention group
Group type: COMPARATOR
Intervention: UCL repair augmented with internal bracing
Number of subjects: 18
Study 27610820 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-iodine-dose dual-energy CTA (21-27 g I)
Number of subjects: 66
Study 27610820 — intervention group
Group type: COMPARATOR
Intervention: Standard-iodine-dose single-energy CTA (30-37 g I)
Number of subjects: 66
Study 24467257 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco treatment intervention
Number of subjects: 693
Study 22088576 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin 320 μg/mL in 4% sodium citrate
Number of subjects: 303
Study 22088576 — intervention group
Group type: COMPARATOR
Intervention: Heparin 1,000 U/mL
Number of subjects: 303
Study 20632509 — intervention group
Group type: EXPERIMENTAL
Intervention: VSD combined with flaps
Number of subjects: 15
Study 20632509 — intervention group
Group type: COMPARATOR
Intervention: Only flaps (non-VSD group)
Number of subjects: 15
Study 17673094 — intervention group
Group type: COMPARATOR
Intervention: Cue group (encouraging discussion)
Number of subjects: 250
Study 17673094 — intervention group
Group type: COMPARATOR
Intervention: PtEd group (patient education handout)
Number of subjects: 250
Study 17673094 — intervention group
Group type: EXPERIMENTAL
Intervention: Control group (standard handout)
Number of subjects: 250
Study 15750150 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-FDG PET
Number of subjects: 10
Study 15750150 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-FLT PET
Number of subjects: 10
Study 15750150 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 18F-FDG PET and 18F-FLT PET
Number of subjects: 10
Study 22276283 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP; 2 mg)
Number of subjects: 6
Study 22276283 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP; 8 mg)
Number of subjects: 6
Study 22276283 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/Naloxone (BUP/NX; 2 mg buprenorphine + 0.5 mg naloxone)
Number of subjects: 6
Study 22276283 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/Naloxone (BUP/NX; 8 mg buprenorphine + 2 mg naloxone)
Number of subjects: 6
Study 22276283 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP)
Number of subjects: 6
Study 22276283 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/Naloxone (BUP/NX)
Number of subjects: 6
Study 22276283 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP) and Buprenorphine/Naloxone (BUP/NX)
Number of subjects: 6
Study 22276283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 10609378 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (anticoagulants)
Number of subjects: 190
Study 10609378 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative duplex scan on the 5th postoperative day
Number of subjects: 190
Study 7740337 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vinorelbine
Number of subjects: 229
Study 1789091 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymetacrylate (PMMA) lens
Number of subjects: 59
Study 1789091 — intervention group
Group type: COMPARATOR
Intervention: Soft hydrogel (IO-gel) lens
Number of subjects: 59
Study 7261900 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone maintenance treatment (MMT)
Number of subjects: 34
Study 7261900 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 34
Study 30535977 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified method of local infiltration (MMLI) during endoscopic stapes surgery
Number of subjects: 70
Study 30535977 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic approach
Number of subjects: 70
Study 30535977 — intervention group
Group type: COMPARATOR
Intervention: Microscopic approach
Number of subjects: 70
Study 30535977 — intervention group
Group type: EXPERIMENTAL
Intervention: MMLI
Number of subjects: 70
Study 28885054 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 97
Study 26342738 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (100 mg/day)
Number of subjects: 44
Study 26342738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 23344273 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate oxytocin infusion
Number of subjects: 190
Study 23344273 — intervention group
Group type: COMPARATOR
Intervention: Delayed oxytocin infusion (4 hours)
Number of subjects: 190
Study 21214631 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (80 mg at week 0; 40 mg every other week from weeks 1-15) with topical vehicle
Number of subjects: 730
Study 21214631 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (80 mg at week 0; 40 mg every other week from weeks 1-15) with topical calcipotriol/betamethasone dipropionate (C/B)
Number of subjects: 730
Study 21214631 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab (80 mg at week 0; 40 mg every other week from weeks 1-15)
Number of subjects: 730
Study 19707226 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Glycemic Index (HGI) diet
Number of subjects: 8
Study 19707226 — intervention group
Group type: COMPARATOR
Intervention: Low-Glycemic Index (LGI) diet
Number of subjects: 8
Study 18260869 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10.8 +/- 0.1 mg/day)
Number of subjects: 101
Study 18260869 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 101
Study 15380903 — intervention group
Group type: EXPERIMENTAL
Intervention: Virgin olive oil (VOO)
Number of subjects: 31
Study 15380903 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil (SO)
Number of subjects: 31
Study 11380321 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 374
Study 11380321 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (metronidazole, amoxicillin, bismuth subsalicylate for 2 weeks, followed by bismuth alone for 14 weeks)
Number of subjects: 374
Study 11380321 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate
Number of subjects: 374
Study 11380321 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy and calcium carbonate
Number of subjects: 374
Study 11380321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 374
Study 9661650 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucine 54 (L) polymorphism
Number of subjects: 199
Study 9661650 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype L/L
Number of subjects: 199
Study 9661650 — intervention group
Group type: EXPERIMENTAL
Intervention: Gln-Arg 192 polymorphism
Number of subjects: 199
Study 7710452 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin (EPR) 60 mg/m2 administered as an i.v. bolus over 2 min
Number of subjects: 10
Study 7710452 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin (EPR) 60 mg/m2 with interferon-alpha-2b (IFN) 5 x 10(6) IU s.c. 3 times a week
Number of subjects: 10
Study 7710452 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin (EPR)
Number of subjects: 10
Study 7710452 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin (EPR) with interferon-alpha-2b (IFN)
Number of subjects: 10
Study 2196493 — intervention group
Group type: COMPARATOR
Intervention: External tocography
Number of subjects: 250
Study 2196493 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal tocography
Number of subjects: 250
Study 518264 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval cycle training (5 days a week for 8 weeks, 4 bouts of 4 minutes each with 3-minute recovery, heart rates 170-195)
Number of subjects: 32
Study 518264 — intervention group
Group type: COMPARATOR
Intervention: Traditional sports-oriented physical education (control group)
Number of subjects: 32
Study 518264 — intervention group
Group type: COMPARATOR
Intervention: Both groups (experimental and control)
Number of subjects: 32
Study 31972236 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 205
Study 31972236 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 205
Study 30707756 — intervention group
Group type: EXPERIMENTAL
Intervention: YWI (educational intervention)
Number of subjects: 467
Study 30707756 — intervention group
Group type: COMPARATOR
Intervention: PAI (contact time control physical activity intervention)
Number of subjects: 467
Study 28135150 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interferon α-2b at 20 MU/m2/d IV for 5 days every week for 4 weeks
Number of subjects: 1150
Study 28135150 — intervention group
Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 1150
Study 28135150 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interferon α-2b
Number of subjects: 1150
Study 25915670 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma Rich in Growth Factors (PRGF)
Number of subjects: 10
Study 25915670 — intervention group
Group type: COMPARATOR
Intervention: Traditional hemostasis
Number of subjects: 10
Study 23474589 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance training (PRT)
Number of subjects: 103
Study 23474589 — intervention group
Group type: COMPARATOR
Intervention: Sham exercise
Number of subjects: 103
Study 20103970 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab-coated stent
Number of subjects: 188
Study 20103970 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stent (BMS)
Number of subjects: 188
Study 18179609 — intervention group
Group type: EXPERIMENTAL
Intervention: Itopride (200 mg t.i.d. for 7 days)
Number of subjects: 25
Study 18179609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 16643825 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporizing management
Number of subjects: 216
Study 16643825 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 216
Study 12649510 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic aspiration with urokinase instilled via catheter over 48 hours (6-hour intervals)
Number of subjects: 71
Study 12649510 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical treatment (control group)
Number of subjects: 71
Study 11142421 — intervention group
Group type: EXPERIMENTAL
Intervention: High mean arterial pressure (MAP)
Number of subjects: 542
Study 11142421 — intervention group
Group type: EXPERIMENTAL
Intervention: High α-fetoprotein (AFP) levels
Number of subjects: 542
Study 11142421 — intervention group
Group type: COMPARATOR
Intervention: Diagnosed preeclampsia
Number of subjects: 542
Study 11142421 — intervention group
Group type: COMPARATOR
Intervention: Hypertension of pregnancy
Number of subjects: 542
Study 8692311 — intervention group
Group type: EXPERIMENTAL
Intervention: D2 resection surgery
Number of subjects: 80
Study 8692311 — intervention group
Group type: COMPARATOR
Intervention: D(1) resection surgery
Number of subjects: 80
Study 8692311 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical protocols and standards developed in the trial
Number of subjects: 80
Study 2058589 — intervention group
Group type: EXPERIMENTAL
Intervention: Atole (moderate energy supplement)
Number of subjects: 4
Study 2058589 — intervention group
Group type: COMPARATOR
Intervention: Fresco (low energy supplement)
Number of subjects: 4
Study 2058589 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Atole group (consumed >= 10% of daily RDI from supplement)
Number of subjects: 4
Study 2058589 — intervention group
Group type: COMPARATOR
Intervention: High-Fresco group (low supplemental energy intake)
Number of subjects: 4
Study 6202387 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent immunotherapy with the methanol extraction residue of bacillus Calmette‐Guerin (MER)
Number of subjects: 204
Study 6202387 — intervention group
Group type: COMPARATOR
Intervention: 5‐fluorouracil and methyl‐CCNU
Number of subjects: 204
Study 6202387 — intervention group
Group type: EXPERIMENTAL
Intervention: MER
Number of subjects: 204
Study 31539073 — intervention group
Group type: EXPERIMENTAL
Intervention: RightRx intervention (electronic medication reconciliation)
Number of subjects: 3491
Study 29413138 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-Feedback Therapy (VFT)
Number of subjects: 144
Study 29413138 — intervention group
Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 144
Study 26624973 — intervention group
Group type: COMPARATOR
Intervention: Filtered back projection
Number of subjects: 20
Study 26624973 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive statistical iterative reconstruction
Number of subjects: 20
Study 26624973 — intervention group
Group type: EXPERIMENTAL
Intervention: Model-based iterative reconstruction (MBIR)
Number of subjects: 20
Study 24229346 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychology intervention program (training based on autobiographical memory, forgiveness, and gratitude)
Number of subjects: 46
Study 24229346 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 46
Study 22114904 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (ABZ) 400 mg daily for 5 days
Number of subjects: 150
Study 22114904 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole (MTZ) 250 mg t.i.d. for 5 days
Number of subjects: 150
Study 20391892 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 minutes of practice viewing 360 pictures of skin lesions
Number of subjects: 100
Study 20391892 — intervention group
Group type: COMPARATOR
Intervention: Viewing a skin cancer pamphlet for 5 minutes
Number of subjects: 100
Study 20391892 — intervention group
Group type: COMPARATOR
Intervention: No practice or practice with a filler task
Number of subjects: 100
Study 17679560 — intervention group
Group type: EXPERIMENTAL
Intervention: Light tower
Number of subjects: 14
Study 17679560 — intervention group
Group type: EXPERIMENTAL
Intervention: Light visor
Number of subjects: 14
Study 17679560 — intervention group
Group type: EXPERIMENTAL
Intervention: Litebook
Number of subjects: 14
Study 17679560 — intervention group
Group type: EXPERIMENTAL
Intervention: LED spectacles
Number of subjects: 14
Study 17679560 — intervention group
Group type: COMPARATOR
Intervention: No phototherapy control
Number of subjects: 14
Study 17874889 — intervention group
Group type: EXPERIMENTAL
Intervention: Contracting, prompting, and reinforcing (CPR)
Number of subjects: 150
Study 17874889 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (STX)
Number of subjects: 150
Study 15853564 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy
Number of subjects: 0
Study 15853564 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lipid-lowering therapy)
Number of subjects: 0
Study 11197057 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein diet (37:50:28, carbohydrate:protein:fat)
Number of subjects: 8
Study 11197057 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced 5:1 carbohydrate:protein diet (105:21:11)
Number of subjects: 8
Study 11197057 — intervention group
Group type: COMPARATOR
Intervention: High carbohydrate diet (126:10:6)
Number of subjects: 8
Study 9184602 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 year treatment (group I)
Number of subjects: 161
Study 9184602 — intervention group
Group type: COMPARATOR
Intervention: 3 years treatment (group II)
Number of subjects: 161
Study 8267059 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol 50 micrograms
Number of subjects: 33
Study 8267059 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol 20 micrograms
Number of subjects: 33
Study 8267059 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol 35 micrograms
Number of subjects: 33
Study 8267059 — intervention group
Group type: EXPERIMENTAL
Intervention: All ethinyl estradiol groups combined
Number of subjects: 33
Study 8267059 — intervention group
Group type: COMPARATOR
Intervention: Norethindrone 1 mg alone
Number of subjects: 33
Study 8267059 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol plus norethindrone
Number of subjects: 33
Study 3162058 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood-sugar lowering sulfonylureas (group II)
Number of subjects: 60
Study 3162058 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-dependent treatment (group III)
Number of subjects: 60
Study 3162058 — intervention group
Group type: COMPARATOR
Intervention: Diet only (group I)
Number of subjects: 60
Study 3162058 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and blood-sugar lowering sulfonylureas (group II)
Number of subjects: 60
Study 31303149 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV risk reduction intervention, the Holistic Health Recovery Program for Malaysia (HHRP‐M)
Number of subjects: 296
Study 31303149 — intervention group
Group type: EXPERIMENTAL
Intervention: pre‐release methadone initiation
Number of subjects: 296
Study 31303149 — intervention group
Group type: COMPARATOR
Intervention: standard care
Number of subjects: 296
Study 31303149 — intervention group
Group type: EXPERIMENTAL
Intervention: forced relocation outside Kuala Lumpur after prison release
Number of subjects: 296
Study 27856954 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface cooling to 34.0°C
Number of subjects: 22
Study 27856954 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface cooling to 34.5°C
Number of subjects: 22
Study 27856954 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface cooling to 35.0°C
Number of subjects: 22
Study 27856954 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 22
Study 25338680 — intervention group
Group type: EXPERIMENTAL
Intervention: Lilac LAB (Bacillus coagulans lilac‐01, 1 × 10(8) CFU)
Number of subjects: 297
Study 25338680 — intervention group
Group type: COMPARATOR
Intervention: Placebo (okara powder, 2 g/d)
Number of subjects: 297
Study 24136378 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose remifentanil (0.1 μg kg min) and preoperative isotonic saline (n=15)
Number of subjects: 60
Study 24136378 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose remifentanil (0.2 μg kg min, increased to clinical demand) and preoperative saline (n=17)
Number of subjects: 60
Study 24136378 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose remifentanil (0.2 μg kg min, increased to clinical demand) and preoperative amantadine (200 mg/500 ml) (n=16)
Number of subjects: 60
Study 21843831 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized application of vibration (3 sessions per week for 8 weeks)
Number of subjects: 30
Study 21843831 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual daily activities)
Number of subjects: 30